Dr. Reddys Labs (RDY), Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug

Go back to Dr. Reddys Labs (RDY), Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug
DR. REDDY'S LAB LTD ADR (NYSE: RDY) Delayed: 12.18 +0.02 (0.16%)
Previous Close $12.16    52 Week High $54.73 
Open $12.33    52 Week Low $40.68 
Day High $12.33    P/E N/A 
Day Low $12.12    EPS $0.00 
Volume 1,674,279